On Thursday, GSK plc (NYSE:GSK) revealed new preliminary data for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) in ...

The CDC’s vaccine advisors on Thursday maintained that respiratory syncytial virus immunization is only recommended for ...

Sanofi and partner AstraZeneca recently increased production capacity for their RSV antibody shot, sales of which jumped ...

This week, Roche RHHBY announced its third-quarter and nine-month results. Sanofi SNY confirmed that it is holding exclusive ...

Pfizer CEO Albert Bourla is in a tough spot as activist investor Starboard Value continues to call for a change in the ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Sanofi and CD&R entered into exclusive negotiations for the potential sale and purchase of a 50% controlling stake in Opella.

2024 Future of Healthcategory US FDA approves Pfizer's RSV vaccine for adults at increased risk of the disease October 22, 2024 ...

Anyone who got sick with COVID-19 during the summer wave in South Florida has some protection against a future infection, but ...

Respiratory syncytial virus, or RSV, typically presents as mild, with symptoms similar to the common cold for adults and ...

Avalon GloboCare signs MOU with Qi Diagnostics to co-develop a nanosensor-based cannabis breathalyzer. Talks aim for a ...

Yesoul, a rising star in the exercise equipment world, is thrilled to announce the launch of its latest treadmill designed to ...